What does CUSIP 514766104 represent in this 13F holders report?

CUSIP 514766104 is the security identifier for LFCR - LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock used to aggregate holder disclosures.

How many institutions held LFCR - LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock in Q2 2023?

73 institutional investors reported LFCR - LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR)

CUSIP: 514766104

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 37,508,353
Total 13F shares: 17,960,139
Share change: -3,648,773
Total reported value: $173,672,855
Put/Call ratio: 151%
Price per share: $9.67
Number of holders: 73
Value change: -$23,585,436
Number of buys: 28
Number of sells: 53

Quarterly Holders Quick Answers

What is CUSIP 514766104?
CUSIP 514766104 identifies LFCR - LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 514766104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of LFCR - LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Greenhaven Road Investment Management, L.P.	13F	Company	2.8%	1,034,449	$39,050,000	—	31 Mar 2023	13F
WYNNEFIELD CAPITAL INC	13F	Company	13%	4,923,545	$18,586,382	—	31 Mar 2023	13F
Legion Partners Asset Management, LLC	13F	Company	7.8%	2,940,340	$11,114,485	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	5.1%	1,898,495	$7,166,819	—	31 Mar 2023	13F
Cove Street Capital, LLC	13F	Company	5%	1,884,344	$7,114,000	—	31 Mar 2023	13F
22NW, LP	13F	Company	4.7%	1,755,161	$6,634,509	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	3.9%	1,464,684	$5,529,182	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	2.3%	869,100	$3,280,853	—	31 Mar 2023	13F
James G. Hall	3/4/5	Chief Executive Officer, Director	— class O/S missing	276,096	$2,876,920	—	01 Jun 2023	3/4/5
TOCQUEVILLE ASSET MANAGEMENT L.P.	13F	Company	1.5%	545,200	$2,058,130	—	31 Mar 2023	13F
Visionary Wealth Advisors	13F	Company	1.3%	500,269	$1,888,516	—	31 Mar 2023	13F
HEARTLAND ADVISORS INC	13F	Company	1.3%	500,000	$1,887,500	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.3%	492,390	$1,858,772	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	1.3%	489,198	$1,846,722	—	31 Mar 2023	13F
Anson Funds Management LP	13F	Company	1.3%	475,062	$1,793,359	—	31 Mar 2023	13F
Russell Investments Group, Ltd.	13F	Company	0.64%	238,836	$901,603	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.61%	227,790	$859,907	—	31 Mar 2023	13F
Albert D. Bolles	3/4/5	Chief Executive Officer	— class O/S missing	72,883	$759,441	—	23 May 2022	3/4/5
Nantahala Capital Management, LLC	13F	Company	0.52%	194,700	$734,992	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.46%	171,451	$647,000	—	31 Mar 2023	13F
Tonia L. Pankopf	3/4/5	Director	— class O/S missing	59,599	$621,022	—	04 Jun 2022	3/4/5
Irenic Capital Management LP	13F	Company	0.41%	155,465	$586,880	—	31 Mar 2023	13F
Catherine A. Sohn	3/4/5	Director	— class O/S missing	54,069	$563,399	—	04 Jun 2022	3/4/5
ROYAL BANK OF CANADA	13F	Company	0.4%	148,467	$561,000	—	31 Mar 2023	13F
CORSAIR CAPITAL MANAGEMENT, L.P.	13F	Company	0.33%	124,928	$471,603	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.33%	124,833	$471,245	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.29%	107,032	$404,047	—	31 Mar 2023	13F
Deborah D. Carosella	3/4/5	Director	— class O/S missing	36,588	$381,247	—	04 Jun 2022	3/4/5
Boston Partners	13F	Company	0.25%	93,558	$353,180	—	31 Mar 2023	13F
Defender Capital, LLC.	13F	Company	0.23%	86,450	$326,349	—	31 Mar 2023	13F
GAMCO INVESTORS, INC. ET AL	13F	Company	0.22%	83,000	$313,325	—	31 Mar 2023	13F
Andrew Kenneth William Powell	3/4/5	Director	— class O/S missing	27,477	$286,310	—	04 Jun 2022	3/4/5
ROYCE & ASSOCIATES LP	13F	Company	0.2%	75,610	$285,428	—	31 Mar 2023	13F
Assenagon Asset Management S.A.	13F	Company	0.2%	75,391	$284,601	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.2%	74,800	$282,370	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.19%	69,828	$263,601	—	31 Mar 2023	13F
Diametric Capital, LP	13F	Company	0.17%	64,920	$245,073	—	31 Mar 2023	13F
Timothy P. Burgess	3/4/5	Senior VP of Supply Chain	— mixed-class rows	30,000 mixed-class rows	$239,704	—	27 Jul 2021	3/4/5
OPPENHEIMER ASSET MANAGEMENT INC.	13F	Company	0.15%	58,000	$218,951	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.14%	52,912	$199,743	—	31 Mar 2023	13F
SIMPLEX TRADING, LLC	13F	Company	0.13%	49,401	$186,000	—	31 Mar 2023	13F
Diversified Trust Co	13F	Company	0.12%	46,062	$173,884	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.11%	41,962	$158,000	—	31 Mar 2023	13F
Belvedere Trading LLC	13F	Company	0.11%	41,176	$155,439	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.1%	38,897	$146,836	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.1%	38,127	$143,929	—	31 Mar 2023	13F
UBS Group AG	13F	Company	0.08%	31,169	$117,663	—	31 Mar 2023	13F
Keene & Associates, Inc.	13F	Company	0.06%	24,100	$90,978	—	31 Mar 2023	13F
Cutter & CO Brokerage, Inc.	13F	Company	0.06%	21,700	$81,918	—	31 Mar 2023	13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	13F	Company	0.06%	21,544	$81,329	—	31 Mar 2023	13F

Institutional Holders of LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR) as of Q2 2023

As of 30 Jun 2023, LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,960,139 shares. The largest 10 holders included WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, 22NW, LP, Cove Street Capital, LLC, VANGUARD GROUP INC, MORGAN STANLEY, BlackRock Inc., Visionary Wealth Advisors, TOCQUEVILLE ASSET MANAGEMENT L.P., and MILLENNIUM MANAGEMENT LLC. This page lists 74 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

-6

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.